Edison, NJ -- (SBWire) -- 10/29/2021 --A new research document is added in HTF MI database of 76 pages, titled as 'Renal Denervation Catheters (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021' with detailed analysis, Competitive landscape, forecast and strategies. Latest analysis highlights high growth emerging players and leaders by market share that are currently attracting exceptional attention. The identification of hot and emerging players is completed by profiling 50+ Industry players; some of the profiled players are Abbott Vascular Inc, Ablative Solutions Inc, AngioCare BV, Brattea, CryoMedix, LLC., Handok-Kalos Medical, Johns Hopkins University, Kona Medical Inc, Lepu Medical Technology (Beijing) Co ,Ltd, Lifetech Scientific (Shenzhen) Co Ltd, Mayo Clinic, Medtronic Plc, MicroPort Scientific Corp, Northwind Medical Inc, ReCor Medical Inc, Renal Dynamics, LLC, Renaly Ltd, Shanghai Bio-heart Biological Technology Co Ltd, Shanghai Golden Leaf Medtech Co Ltd, SoniVie Inc, Sound Interventions, Inc., St. Jude Medical LLC, Suzhou SyMap Medical Ltd, Symple Surgical Inc, Tel Aviv University, Terumo Interventional Systems, University of Sydney, Verve Medical.
Access sample report @ https://www.htfmarketreport.com/sample-report/3657828-renal-denervation-catheters-1
Summary
HTF MI Medical Devices sector report, "Renal Denervation Catheters (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Renal Denervation Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Renal denervation, also known as renal sympathetic denervation (RSD), is a minimally invasive, catheter-based endovascular procedure that utilizes radiofrequency energy or ultrasound energy to ablate nerves in the walls of the renal artery, causing a reduction in the nerve activity which ultimately reduces the blood pressure in patients with resistant hypertension.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Renal Denervation Catheters under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Renal Denervation Catheters and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Renal Denervation Catheters under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Companies Mentioned in the Report
Abbott Vascular Inc
Ablative Solutions Inc
AngioCare BV
Brattea
CryoMedix, LLC.
Handok-Kalos Medical
Johns Hopkins University
Kona Medical Inc
Lepu Medical Technology (Beijing) Co Ltd
Lifetech Scientific (Shenzhen) Co Ltd
Mayo Clinic
Medtronic Plc
MicroPort Scientific Corp
Northwind Medical Inc
ReCor Medical Inc
Renal Dynamics, LLC
Renaly Ltd
Shanghai Bio-heart Biological Technology Co Ltd
Shanghai Golden Leaf Medtech Co Ltd
SoniVie Inc
Sound Interventions, Inc.
St. Jude Medical LLC
Suzhou SyMap Medical Ltd
Symple Surgical Inc
Tel Aviv University
Terumo Interventional Systems
University of Sydney
Verve Medical, Inc.
Get Customization in the Report, Enquire Now @ https://www.htfmarketreport.com/enquiry-before-buy/3657828-renal-denervation-catheters-1
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Renal Denervation Catheters Overview
3 Products under Development
3.1 Renal Denervation Catheters - Pipeline Products by Stage of Development
3.2 Renal Denervation Catheters - Pipeline Products by Segment
3.3 Renal Denervation Catheters - Pipeline Products by Territory
3.4 Renal Denervation Catheters - Pipeline Products by Regulatory Path
3.5 Renal Denervation Catheters - Pipeline Products by Estimated Approval Date
3.6 Renal Denervation Catheters - Ongoing Clinical Trials
4 Renal Denervation Catheters - Pipeline Products under Development by Companies
4.1 Renal Denervation Catheters Companies - Pipeline Products by Stage of Development
4.2 Renal Denervation Catheters - Pipeline Products by Stage of Development
5 Renal Denervation Catheters Companies and Product Overview
5.1 Abbott Vascular Inc Company Overview
5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Ablative Solutions Inc Company Overview
....Continued
View Detailed Table of Content @ https://www.htfmarketreport.com/reports/3657828-renal-denervation-catheters-1
It's vital you keep your market knowledge up to date. If you have a different set of players/manufacturers according to geography or needs regional or country segmented reports we can provide customization accordingly.
Purchase Single User License of this report at @ https://www.htfmarketreport.com/buy-now?format=1&report=3657828
Contact Us:
CRAIG FRANCIS (PR & Marketing Manager)
sales@htfmarketreport.com
Ph: +1 (206) 317 1218
